Form 4 for MXCT MAXCYTE, INC.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001209191-23-006880 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-03 | 2023-02-01+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $2.04 | +29.1K | 2,468 | New | +$59.5K |
| DM | 2023-02-03 | 2023-02-01+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $5.72 | -29.1K | 0 | -100% | -$166.5K |
| DM | 2023-02-03 | 2023-02-01+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $0.00 | -29.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | M | A | 15,090 | $2.14 | 17,558 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-02 | S | D | 11,575 | $5.77 | 0 | D | — | — | (F3) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.69 to $5.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2023-02-02 | M | A | 11,575 | $2.14 | 11,575 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-01 | S | D | 17,558 | $5.68 | 0 | D | — | — | (F2) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.51 to $5.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2023-02-01 | M | A | 2,468 | $0.98 | 2,468 | D | — | — | |
| 6 | Derivative | Employee Stock Option (right to buy) | 2023-02-01 | M | D | 15,090 | $0.00 | 83,710 | D | $2.14 · — to 2029-03-04 | 15,090 Common Stock | (F5) The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2023-02-02 | M | D | 11,575 | $0.00 | 72,135 | D | $2.14 · — to 2029-03-04 | 11,575 Common Stock | (F5) The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2023-02-01 | M | D | 2,468 | $0.00 | 0 | D | $0.98 · — to 2026-06-13 | 2,468 Common Stock | (F4) This option is fully vested and exercisable. |